Wockhardt Limited

Wockhardt is an Indian pharmaceuticals company headquartered in Mumbai, India. It was founded in 1967 by Dr. Habil Khorakiwala and is primarily engaged in the manufacture of generic drugs and specialty pharmaceuticals. In 2022, Wockhardt’s revenue was approximately INR 3,500 crores.

Wockhardt Limited has a diversified portfolio of products, ranging from antibiotics, vaccines, biopharmaceuticals, generics, OTC products, and active pharmaceutical ingredients (APIs). The company has a strong focus on research and development (R&D), with over 600 scientists working in six state-of-the-art facilities. Wockhardt Limited has also established several collaborations and partnerships with global institutions and organizations, such as the World Health Organization (WHO), the Bill and Melinda Gates Foundation, the UK Department of Health, and the US Food and Drug Administration (FDA).

Wockhardt Limited's vision is to be a global leader in affordable and innovative healthcare solutions, with a mission to improve the quality of life of millions of people around the world. The company's core values are excellence, integrity, innovation, teamwork, and customer-centricity.

Wockhardt Limited is committed to social responsibility, sustainability and has undertaken various initiatives to support education, health, environment, and community development. Some of these initiatives include the Wockhardt Foundation, the Wockhardt Hospitals, the Wockhardt Institute of Aesthetics, and the Wockhardt Skills Development Centre.

Foundation: 1967
Headquarters: Mumbai, Maharashtra

Website: https://www.wockhardt.com/